July 30 (Reuters) - Dexcom ( DXCM ) beat estimates for

second-quarter results on Wednesday, driven by strong demand for

its continuous glucose monitors, and named Jake Leach as its

CEO.

Leach, who is currently president and chief operating

officer of the company, will succeed Kevin Sayer from January 1.

Dexcom ( DXCM ) said Sayer will continue to work closely with Leach

during the transition period and will remain executive chairman

of the board at the point of transition.

The CGM maker also revised its annual revenue forecast to a

range of $4.60 billion to $4.63 billion, compared with its

previous expectation of $4.60 billion. Analysts on average

expect 2025 revenue of $4.62 billion, according to data compiled

by LSEG.

Increasing diabetes care awareness, wider insurance coverage

and preference for devices that do not need finger pricks have

helped drive demand for CGMs such as Dexcom's ( DXCM ) Stelo and G7.

Dexcom ( DXCM ) is pinning its hopes on Stelo, its recently launched

device for adults aged 18 and older who do not use insulin,

making it the first CGM available for over-the-counter sales.

The San Diego, California-based company reported

second-quarter revenue of $1.16 billion, beating analysts

estimates of $1.12 billion.

On an adjusted basis, the company earned a profit of 48

cents per share, compared with estimates of 44 cents per share.

(Reporting by Christy Santhosh in Bengaluru; Editing by Anil

D'Silva)